What is Impladent?
For over three decades, Impladent Ltd. has functioned as a cornerstone in the dental regenerative products market. The company specializes in the engineering and distribution of synthetic resorbable bone grafts, including its flagship OsteoGen plugs and comprehensive socket preservation accessories. By prioritizing clinical efficacy and patient safety, Impladent has established a robust reputation among oral health practitioners. Their business model integrates advanced material science with practical dental applications, ensuring that clinicians have access to reliable, high-performance solutions for complex oral surgeries. As a mature entity in the medical device space, the company maintains a focus on consistent product innovation and supply chain reliability.
How much funding has Impladent raised?
Impladent has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Impladent
PPP
Public-Private Partnership
What's next for Impladent?
Following this major strategic investment, Impladent is well-positioned to accelerate its growth trajectory within the global dental market. The capital will likely be directed toward enhancing production capacity to meet the rising demand for regenerative dental solutions and potentially exploring new material science research to broaden its product portfolio. By reinforcing its infrastructure, Impladent aims to maintain its competitive edge against emerging biotech entrants while deepening its penetration into international dental markets. The firm's focus remains on scaling its operational efficiency to ensure that its innovative bone grafting technologies remain accessible to a growing base of dental professionals worldwide.
See full Impladent company page
